BCL2 and neoplasm: However, a set of chemotherapeutics, as well as, inhibitors of Bcl-2 family, PI3K, HDAC, mTOR and 20S proteasome, yielded a significant decrease in the tumor cell number of GSCs and GdECs (Fig. 2A).